HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome.

AuthorsD Dressler, M Wittstock, R Benecke
JournalEuropean neurology (Eur Neurol) Vol. 45 Issue 4 Pg. 287-8 ( 2001) ISSN: 0014-3022 [Print] Switzerland
PMID11385272 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Neuromuscular Agents
  • Botulinum Toxins, Type A
Topics
  • Adult
  • Botulinum Toxins, Type A (administration & dosage, therapeutic use)
  • Dystonic Disorders (complications, drug therapy)
  • Humans
  • Injections, Intramuscular
  • Jaw Diseases (complications, drug therapy)
  • Male
  • Neuromuscular Agents (administration & dosage, therapeutic use)
  • Pantothenate Kinase-Associated Neurodegeneration (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: